Key facts
- Gradient Health’s last known valuation is $15.0M (Jun 2023).
- It has raised $5.5M across 2 recorded rounds; the latest was Seed Round ($2.4M) in Jun 2023.
- Notable investors include Techstars, Impact Assets, Triangle Tweener Fund, Verissimo Ventures, Catalyst by Wellstar — 18 tracked in total.
- Gradient Health has filed 3 Form Ds with the SEC since 2022, most recently Apr 2025 ($100K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Gradient Health
Funding rounds
2 roundsAbout Gradient Health
Developer of an open research platform designed to offer AI-based medical imaging diagnostics and infrastructure. The company's platform utilizes artificial intelligence to offer access to the full clinical sandbox, open-source tooling, and free and instantly available documentation, enabling developers to translate research into an interoperable, secure clinical environment easily.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2018
- Employees
- 42
- Website
- gradienthealth.io/
- Ownership
- Privately Held (backing)
Gradient Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gradient Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gradient Health in its N-PORT filings yet. We sweep new filings monthly.